Fidelity Investments’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-574,734
| Closed | -$1.95M | – | 4445 |
|
|
2018
Q3 | $1.95M | Buy |
+574,734
| New | +$1.95M | ﹤0.01% | 2372 |
|
|
2018
Q2 | – | Sell |
-1,343,145
| Closed | -$5.49M | – | 2778 |
|
|
2018
Q1 | $5.49M | Sell |
1,343,145
-348,619
| -21% | -$1.43M | ﹤0.01% | 2133 |
|
|
2017
Q4 | $7.87M | Sell |
1,691,764
-550,900
| -25% | -$2.56M | ﹤0.01% | 2020 |
|
|
2017
Q3 | $15.9M | Sell |
2,242,664
-72,000
| -3% | -$511K | ﹤0.01% | 1773 |
|
|
2017
Q2 | $16.7M | Hold |
2,314,664
| – | – | ﹤0.01% | 1752 |
|
|
2017
Q1 | $14.3M | Sell |
2,314,664
-155,500
| -6% | -$958K | ﹤0.01% | 1832 |
|
|
2016
Q4 | $14.5M | Sell |
2,470,164
-698,500
| -22% | -$4.09M | ﹤0.01% | 1816 |
|
|
2016
Q3 | $16.8M | Hold |
3,168,664
| – | – | ﹤0.01% | 1759 |
|
|
2016
Q2 | $21M | Buy |
3,168,664
+984,472
| +45% | +$6.52M | ﹤0.01% | 1657 |
|
|
2016
Q1 | $10.2M | Sell |
2,184,192
-2,242,300
| -51% | -$10.5M | ﹤0.01% | 1953 |
|
|
2015
Q4 | $22.4M | Sell |
4,426,492
-55,005
| -1% | -$278K | ﹤0.01% | 1637 |
|
|
2015
Q3 | $15.8M | Sell |
4,481,497
-638,895
| -12% | -$2.25M | ﹤0.01% | 1746 |
|
|
2015
Q2 | $51.1M | Sell |
5,120,392
-266,100
| -5% | -$2.66M | 0.01% | 1328 |
|
|
2015
Q1 | $68.6M | Buy |
5,386,492
+1,385,700
| +35% | +$17.6M | 0.01% | 1206 |
|
|
2014
Q4 | $56.6M | Sell |
4,000,792
-10,200
| -0.3% | -$144K | 0.01% | 1272 |
|
|
2014
Q3 | $55.2M | Buy |
4,010,992
+215,292
| +6% | +$2.96M | 0.01% | 1263 |
|
|
2014
Q2 | $58.4M | Buy |
3,795,700
+145,500
| +4% | +$2.24M | 0.01% | 1275 |
|
|
2014
Q1 | $62.2M | Buy |
3,650,200
+1,024,100
| +39% | +$17.5M | 0.01% | 1221 |
|
|
2013
Q4 | $34M | Buy |
+2,626,100
| New | +$34M | ﹤0.01% | 1499 |
|
|
2013
Q3 | – | Sell |
-468,000
| Closed | -$3.5M | – | 2702 |
|
|
2013
Q2 | $3.5M | Buy |
+468,000
| New | +$3.5M | ﹤0.01% | 2223 |
|